Global Expansion Cerus Corporation is actively expanding its footprint globally by providing vital technologies and pathogen-protected blood components to blood centers and hospitals worldwide. This presents an opportunity for sales teams to explore markets beyond the US and tap into international demand for safe blood products.

Product Portfolio Growth With the continued development of its INTERCEPT red blood cell system and other innovative products, Cerus is enhancing its product portfolio. Sales professionals can capitalize on this growth by promoting these new offerings to existing and potential clients, showcasing the company's commitment to technological advancement and enhanced blood safety.

Revenue Performance Cerus Corporation demonstrated strong revenue performance, exceeding its product revenue guidance in 2024. This financial stability provides a strong foundation for sales teams to leverage the company's success and credibility when approaching potential customers, reinforcing Cerus as a reliable partner in the biotechnology research industry.

Industry Recognition Cerus' participation in global events like the 2024 AABB Annual Meeting showcases its thought leadership and dedication to advancements in transfusion medicine. Sales professionals can capitalize on this industry recognition by aligning the company's reputation with innovative solutions, positioning Cerus as a front-runner in the blood products sector.

Competitive Advantage In a landscape with similar companies like Asahi Kasei and Haemonetics, Cerus' unique focus on pathogen-protected blood components sets it apart. Sales teams can highlight this competitive advantage to emphasize the superior safety standards of Cerus' products, appealing to healthcare institutions and blood centers prioritizing quality and patient safety.